Biomaterials Market

Biomaterials Market Size & Trends

The global biomaterials market, valued at $45.2 billion in 2024, is projected to reach $64.2 billion by 2029, growing at a CAGR of 7.3%. This growth is driven by increased funding in regenerative and personalized medicine, the use of biomaterials in various therapeutic areas, and rising demand in wound healing, plastic surgery, and implantable devices. However, biocompatibility issues may hinder this growth. Key market trends include a shift towards bio-absorbable biomaterials and advancements in orthopedic applications. The market is segmented by type (metallic, polymeric, ceramic, natural) and application (cardiovascular, orthopedic, dental, plastic surgery, etc.), with North America leading in market share and the Asia Pacific region expected to exhibit the highest growth rate. Major players include BASF SE, Covestro AG, Celanese Corporation, and Evonik Industries AG. Recent developments highlight a focus on sustainability and innovation in biomaterial products.

Biomaterials Market Market Size, Dynamics & Ecosystem

To know about the assumptions considered for the study, Request for Free Sample Report

Global Biomaterials market Dynamics

Driver: Growing demand for biomaterials in wound healing and plastic surgery

Plastic surgery and wound healing are prominent application areas for biomaterial-based products. In plastic surgery, biomaterials are widely used to implant, rebuild, repair, and cover soft tissue wounds, burns, or gaping holes in the human body naturally and safely. The surge in demand for biomaterials in wound healing and plastic surgery is a significant driver within the medical industry. There has been a notable increase in the adoption of biomaterials, driven by their proven efficacy in promoting enhanced healing processes and reducing infection rates in medical procedures..

Restraint: Biocompatibility issues

Orthopedic injuries and associated pathologies represent a significant global public health concern and a substantial burden of disability and suffering. In the global context, there was a notable surge in musculoskeletal disorders, with a recorded total of 494 million individuals affected in 2020. This signifies a substantial rise of 123.4% compared to the 1990 statistics, which reported 221 million cases. These orthopedic conditions often necessitate surgical interventions, involving the utilization of permanent, temporary, or biodegradable medical devices. These devices incorporate various natural or synthetic biomaterials designed to substitute or repair different tissues, such as ligaments, tendons, cartilage, and bone. The success of orthopedic interventions relies significantly on the careful consideration of factors like the design of the medical device, the functional properties of biomaterials, and the biological response.

Opportunity: Growing interest in bio-absorbable biomaterials

Bioresorbable refers to a substance that when introduced into the human body, initiates a process of dissolution (resorption) and gradual replacement by advancing tissue, such as bone. Examples of bioresorbable materials include tricalcium phosphate [Ca3(PO4)2] and copolymers of polylactic acid and polyglycolic acid. In the past three decades, commonly utilized materials with bioresorbable properties also encompass calcium oxide, calcium carbonate, and gypsum. The biomaterials industry is witnessing a surge in interest in bioabsorbable biomaterials, indicating a paradigm shift in the field. According to data from reputable industry reports between 2021–2024, this growing interest is substantiated by a notable increase in investments, with major companies focusing on research, development, and commercialization of bioabsorbable materials. Examples include the Absorv range of bioabsorbable products by Zeus Company Inc. (EQT AB) and the RESOMER range of bioresorbable materials by Evonik Industries AG.

Challenge: Durability and long-term performance issues

The biomaterials market is expanding at a fast pace; however, long-term durability and performance pose a challenge to the market growth. Maintaining functionality and efficacy over time poses a major challenge, impacting patient outcomes and market potential. Furthermore, biomaterials find widespread applications in various medical devices, encompassing implants, scaffolds, dental products, prostheses, stents, catheters, and artificial organs. Following the fulfillment of their intended purposes, these biomaterials undergo replacement or removal. With the escalating significance of biomaterials in the realm of medicine, their accumulation and disposal in medical waste pose a growing challenge. Commonly, waste biomaterials are either deposited in landfills or subjected to incineration. However, given their potential infectious nature, biomaterials discarded in landfills may pose environmental risks, contributing to soil and water pollution during degradation. Conversely, insufficient incineration of biomaterials may result in the emission of harmful chemical compounds into the atmosphere. Hence, the imperative to address biomaterial recycling is of immediate concern. These are the major reasons why maintenance of durability and performance in the long run and waste management of biomaterials can limit their use.

Biomaterials Market Segmentation & Geographical Spread

To know about the assumptions considered for the study, download the pdf brochure

The metallic biomaterials segment commanded market share of biomaterials industry in 2023.

On the basis of type, the biomaterials market is segmented into metallic (stainless steel, titanium & titanium alloys, cobalt-chrome alloys, gold, silver,  magnesium, and other metallic biomaterials), polymeric (polymethylmethacrylate, polyethylene, polyester, polyvinylchloride, silicone rubber, nylon, polyetheretherketone, other polymeric biomaterials), ceramic (calcium phosphate, zirconia, aluminum oxide, calcium sulfate, carbon and glass) and natural (hyaluronic acid, collagen, fibrin, cellulose, chitin, alginate, gelatin, chitosan, silk, other natural biomaterials). The metallic biomaterials segment dominated the market in 2023. The advancements in material science and manufacturing technologies and increasing demand for orthopedic implants are a few of the many factors driving the growth of this segment.

The orthopedic application is poised to exhibit substantial growth at a notable CAGR throughout the biomaterials industry forecast period.

Based on application, the biomaterials market is classified into Cardiovascular (Heart Valves, Stents, Cardiac Defibrillators, Guidewires, Sensors, Catheters, Vascular Grafts, Other Cardiovascular Products), Implantable Wound Healing (Skin Substitutes, Wound Closure Devices, [Sutures, Staples], Surgical Hemostats, Adhesion Barriers, Hernia Meshes, Internal Tissue Sealants), Orthopedic (Joint Replacement [Knee Replacement, Shoulder Replacement, Hip Replacement, Other Joint Replacement Procedures], Spine Surgery, [Minimally Invasive Fusion, Motion Preservation & Dynamic Stabilization {Pedicle-based Rod Systems, Interspinous Spacers, Artificial Discs}, Spinal Fusion], Bioresorbable Tissue Fixation [Meniscal Repair Tacks, Suture Anchors, Interference Screws, Meshes], Orthobiologics, Fracture Fixation [Wires, Screws, Bone Plates, Pins, Rods]), Urinary (Urinary Catheters, Urethral Stents, Other Urinary Products), Dental (Dental Implants, Tissue Regeneration Materials, Dental Bone Grafts & Substitutes, Dental Membranes), Plastic Surgery (Facial Wrinkle Treatment Devices, Acellular Dermal Matrices, Bioengineered Skins, Craniofacial Surgery Products, Peripheral Nerve Repair Devices, Soft Tissue Fillers), Tissue Engineering (Scaffolds, Inorganic Nanoparticles, Nanomaterials), Neurological/Central Nervous System (Cortical Neural Prosthetics, Shunting Systems, Neural Stem Cell Encapsulation Products, Hydrogel Scaffolds), Ophthalmology (Contact Lenses, Functional Replacement of Ocular Tissues, Intraocular Lenses, Synthetic Corneas, Other Ophthalmology Products), and Other Applications (Drug Delivery Systems, Bariatric Surgery, Gastrointestinal). In 2023, the orthopedic sector dominated the global market, primarily driven by heightened research into musculoskeletal regeneration and the growing incidence of orthopedic conditions.

Biomaterials Industry, Asia Pacific predicted to exhibit highest CAGR during the forecast period of 2024-2029.

There are six main regional segmentations for the biomaterials market—North America, Europe, the Asia Pacific, Latin America, Middle East and Africa. In 2023, North America was estimated to account for the highest market share. Advanced healthcare infrastructure, favorable regulatory environment and increasing incidence of chronic diseases are driving the North American market's robust growth. Additionally, Asia Pacific was estimated to exhibit the highest CAGR which can be attributed to the increase in the aging population, rising new technologies demand and increasing burden of chronic diseases.

Key players in the Market include BASF SE (Germany), Covestro AG (Germany), Celanese Corporation (US), Carpenter Technology Corporation (US), DSM (Netherlands), Corbion NV (Netherlands), Evonik Industries AG (Germany), Victrex Plc (UK), CeramTec GmbH (Germany), Mitsubishi Chemical Group Corporation (Japan), CoorsTek Inc. (US), Berkeley Advanced Biomaterials (US), CAM Bioceramics B.V. (Netherlands), Zeus Company Inc. (US), AMETEK Inc. (US), and GELITA AG (Germany).

Scope of the Biomaterials Industry

This report categorizes the biomaterials market to forecast revenue and analyze trends in each of the following submarkets:

By Type

• Metallic Biomaterials
  • Stainless Steel
  • Titanium & Titanium Alloys
  • Cobalt-chrome Alloys
  • Silver
  • Gold
  • Magnesium
  • Other Metallic Biomaterials
• Ceramic Biomaterials
  • Aluminum Oxide
  • Zirconia
  • Calcium Phosphate
  • Calcium Sulfate
  • Carbon
  • Glass
• Polymeric Biomaterials
  • Polymethylmethacrylate
  • Polyethylene
  • Polyester
  • Polyvinylchloride
  • Silicone Rubber
  • Nylon
  • Polyetheretherketone
  • Other Polymeric Biomaterials
• Natural Biomaterials
  • Hyaluronic Acid
  • Collagen
  • Fibrin
  • Cellulose
  • Chitin
  • Alginate
  • Gelatin
  • Silk
  • Chitosan
  • Other Natural Biomaterials
• Cell therapy
  • Stem cell therapy
    • Cell transplantations
    • Stem cell therapy products
      • Autologous therapy
      • Allogenic therapy
  • Cell-based immunotherapy products
• Gene therapy
• Tissue engineering

By Application

• Cardiovascular
  • Catheters
  • Stents
  • Implantable Cardiac Defibrillators
  • Sensors
  • Heart Valves
  • Vascular Grafts
  • Guidewires
  • Other Cardiovascular Products
• Orthopedic
  • Joint Replacement
    • Knee Replacement
    • Hip Replacement
    • Shoulder Replacement
    • Other Joint Replacement Procedures
  • Spine Surgery
    • Spinal Fusion
    • Minimally Invasive Fusion
    • Motion Preservation & Dynamic Stabilization
      • Pedicle-based Rod Systems
      • Interspinous Spacers
      • Artificial Discs
  • Bioresorbable Tissue Fixation
    • Suture Anchors
    • Interference Screws
    • Meniscal Repair Tacks
    • Meshes
  • Orthobiologics
  • Fracture Fixation
    • Bone Plates
    • Screws
    • Pins
    • Rods
    • Wires
• Ophthalmology
  • Contact Lenses
  • Intraocular Lenses
  • Functional Replacement of Ocular Tissues
  • Synthetic Corneas
  • Other Ophthalmology Products
• Dental
  • Dental Implants
  • Dental Bone Grafts & Substitutes
  • Dental Membranes
  • Tissue Regeneration Materials
• Plastic Surgery
  • Soft Tissue Fillers
  • Craniofacial Surgery Products
  • Facial Wrinkle Treatment Devices
  • Bioengineered Skins
  • Peripheral Nerve Repair Devices
  • Acellular Dermal Matrices
• Wound Healing
  • Wound Closure Devices
    • Sutures
    • Staples
  • Internal Tissue Sealants
  • Surgical Hemostats
  • Adhesion Barriers
  • Hernia Meshes
  • Skin Substitutes
• Tissue Engineering
  • Scaffolds
  • Nanomaterials
  • Inorganic Nanoparticles
• Neurological/Central Nervous System
  • Shunting Systems
  • Cortical Neural Prosthetics
  • Hydrogel Scaffolds
  • Neural Stem Cell Encapsulation Products
• Urinary
  • Urinary Catheters
  • Urethral Stents
  • Other Urinary Products
• Other Applications
  • Drug Delivery Systems
  • Gastrointestinal
  • Bariatric Surgery

By Region

• North America
  • US
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East
  • GCC
    • Saudi Arabia (KSA)
    • United Arab Emirates (UAE)
    • Rest of GCC
  • Rest of Middle East
• Africa

Recent Developments of Biomaterials Industry:

• In October 2022, BASF launched two new sustainable product families: Ultraform LowPCF (Low Product Carbon Footprint) and Ultraform BMB (Biomass Balance) to support the sustainability goals of the customer. BASF has designated Ultraform as its trademark for the polyoxymethylene (POM) portfolio. Ultraform LowPCF presents a Product Carbon Footprint that surpasses conventional Ultraform grades by a minimum of 30% through the utilization of green electricity and the implementation of energy-efficient technology.
• In February 2023, Covestro launched Makrolon 3638 polycarbonate for use in both healthcare and life science applications. This polycarbonate grade is durable, with the ability to withstand everyday use while maintaining structural integrity.
• In September 2022, Celanese Corporation entered into a strategic agreement with polymer distributor Ravago for Celanese's Santoprene and Geolast TPV portfolio in North American countries, such as the US, Canada, and Mexico.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst